Pandox Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Pandox kazanç ve gelirin sırasıyla yıllık 47.7% ve 6.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 47% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 5.4% olacağı tahmin edilmektedir.

Anahtar bilgiler

47.7%

Kazanç büyüme oranı

47.0%

EPS büyüme oranı

Real Estate kazanç büyümesi	61.2%
Gelir büyüme oranı	6.8%
Gelecekteki özkaynak getirisi	5.4%
Analist kapsamı	Low
Son güncelleme	15 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Industry Analysts Just Upgraded Their Pandox AB (publ) (STO:PNDX B) Revenue Forecasts By 16%

Oct 28

Is Pandox (STO:PNDX B) Using Too Much Debt?

Sep 26

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

May 30

Analysts Just Made A Stunning Upgrade To Their Pandox AB (publ) (STO:PNDX B) Forecasts

Feb 12

Pandox (STO:PNDX B) Has A Somewhat Strained Balance Sheet

Jan 15

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Sep 18

Pandox (STO:PNDX B) May Have Issues Allocating Its Capital

Jun 27

Pandox (STO:PNDX B) Seems To Be Using A Lot Of Debt

May 31

Kazanç ve Gelir Büyüme Tahminleri

OM:PNDX B - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SEK Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	8,174	1,858	1,112	2,383	1
12/31/2025	7,790	1,754	1,027	2,282	1
12/31/2024	7,139	1,524	-2,302	1,797	1
9/30/2024	7,078	-2	1,699	1,746	N/A
6/30/2024	7,089	495	1,736	1,783	N/A
3/31/2024	6,997	78	1,596	1,643	N/A
12/31/2023	6,849	-585	2,146	2,193	N/A
9/30/2023	6,774	648	2,190	2,222	N/A
6/30/2023	6,478	1,876	2,603	2,635	N/A
3/31/2023	6,014	2,959	2,579	2,611	N/A
12/31/2022	5,537	4,217	2,345	2,377	N/A
9/30/2022	4,740	4,355	2,037	2,134	N/A
6/30/2022	4,069	2,988	1,308	1,405	N/A
3/31/2022	3,389	1,611	827	924	N/A
12/31/2021	3,247	610	333	430	N/A
9/30/2021	2,968	51	394	461	N/A
6/30/2021	2,850	-368	350	417	N/A
3/31/2021	2,821	-691	83	150	N/A
12/31/2020	3,178	-1,399	393	460	N/A
9/30/2020	3,946	198	368	478	N/A
6/30/2020	4,598	543	841	951	N/A
3/31/2020	5,453	1,632	1,313	1,423	N/A
12/31/2019	5,553	2,706	1,824	1,934	N/A
9/30/2019	5,473	2,185	2,283	2,348	N/A
6/30/2019	5,363	2,776	1,823	1,888	N/A
3/31/2019	5,263	2,777	2,010	2,075	N/A
12/31/2018	5,124	2,820	1,645	1,710	N/A
9/30/2018	4,848	3,232	1,557	1,685	N/A
6/30/2018	4,559	2,945	N/A	1,877	N/A
3/31/2018	4,326	3,068	N/A	1,678	N/A
12/31/2017	4,269	3,140	N/A	1,693	N/A
9/30/2017	4,247	2,719	N/A	1,306	N/A
6/30/2017	4,235	2,761	N/A	1,286	N/A
3/31/2017	4,112	2,349	N/A	1,242	N/A
12/31/2016	3,945	2,201	N/A	1,195	N/A
9/30/2016	3,769	2,115	N/A	1,155	N/A
6/30/2016	3,661	1,951	N/A	1,237	N/A
3/31/2016	3,658	2,131	N/A	1,056	N/A
12/31/2015	3,529	2,131	N/A	864	N/A
9/30/2015	3,432	1,575	N/A	1,057	N/A
6/30/2015	3,281	1,390	N/A	830	N/A
3/31/2015	3,112	1,276	N/A	830	N/A
12/31/2014	3,076	1,253	N/A	881	N/A
12/31/2013	2,897	948	N/A	540	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: PNDX B önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 1.2% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: PNDX B önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: PNDX B önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: PNDX B şirketinin gelirinin (yıllık 6.8% ) Swedish pazarından (yıllık -0.04% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: PNDX B şirketinin gelirinin (yıllık 6.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: PNDX B 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 5.4 %).

Pandox Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates increase by 17%

Price target increased by 8.7% to kr188

Consensus EPS estimates fall by 13%

Consensus EPS estimates fall by 31%

Price target decreased by 13% to kr143

Consensus EPS estimates fall by 12%

Recent updates

Third quarter 2024 earnings: EPS misses analyst expectations

Pandox AB (publ) (OM:PNDX B) completed the acquisition of DoubleTree by Hilton Edinburgh.

New minor risk - Shareholder dilution

Chief Executive Officer recently bought kr504k worth of stock

Pandox AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 2.000058 billion.

Pandox AB (publ), Annual General Meeting, Apr 09, 2025

Pandox AB (publ) (OM:PNDX B) entered into an agreement to acquire DoubleTree by Hilton Edinburgh for £49 million.

Pandox AB (publ) (OM:PNDX B) entered into an agreement to acquire DoubleTree by Hilton Edinburgh for £49 million.

Insider recently sold kr485m worth of stock

Consensus EPS estimates increase by 17%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 8.7% to kr188

Pandox AB (publ) to Report Q1, 2025 Results on Apr 29, 2025

Some Investors May Be Willing To Look Past Pandox's (STO:PNDX B) Soft Earnings

First quarter 2024 earnings released

An unknown buyer completed the acquisition of DoubleTree by Hilton Montreal from Pandox AB (publ) (OM:PNDX B).

Pandox AB (Publ) Approves Dividend

Upcoming dividend of kr4.00 per share

Pandox's (STO:PNDX B) Dividend Will Be Increased To SEK4.00

Full year 2023 earnings: EPS misses analyst expectations

Dividend increased to kr4.00

Pandox AB (publ) to Report Fiscal Year 2023 Results on Mar 08, 2024

Pandox AB (publ) Proposes a Dividend

Full year 2023 earnings: EPS misses analyst expectations

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2024 Results on Feb 06, 2025

Third quarter 2023 earnings released: EPS: kr2.48 (vs kr9.16 in 3Q 2022)

Pandox (STO:PNDX B) Takes On Some Risk With Its Use Of Debt

Pandox AB (publ), Annual General Meeting, Apr 10, 2024

Consensus EPS estimates fall by 13%

New minor risk - Profit margin trend

Second quarter 2023 earnings: Revenues exceed analyst expectations

Consensus EPS estimates fall by 31%

Does Pandox (STO:PNDX B) Have A Healthy Balance Sheet?

Price target decreased by 13% to kr143

Insider recently bought kr895k worth of stock

First quarter 2023 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Upcoming dividend of kr2.50 per share at 2.0% yield

Key Executive recently bought kr536k worth of stock

With EPS Growth And More, Pandox (STO:PNDX B) Makes An Interesting Case

Insider recently bought kr429k worth of stock

Chief Commercial Officer recently bought kr282k worth of stock

Chief Executive Officer recently bought kr490k worth of stock

Consensus EPS estimates fall by 12%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Pandox AB (publ) Proposes Dividend for 2022

An unknown buyer acquired InterContinental from Montreal Pandox AB (publ) (OM:PNDX B) for CAD 80 million.

Is Now An Opportune Moment To Examine Pandox AB (publ) (STO:PNDX B)?

Pandox AB (publ) to Report Fiscal Year 2022 Results on Mar 10, 2023

Second quarter 2022 earnings released: EPS: kr7.45 (vs kr0.038 loss in 2Q 2021)

Consensus EPS estimates increase by 44%

Industry Analysts Just Upgraded Their Pandox AB (publ) (STO:PNDX B) Revenue Forecasts By 16%

Pandox AB (publ) to Report Fiscal Year 2022 Results on Feb 10, 2023

Is Pandox (STO:PNDX B) Using Too Much Debt?

Pandox AB (publ) (OM:PNDX B) acquired Hotel in the UK from Starwood Capital Operations, LLC for £40 million.

Pandox AB (publ) Announces Nomination Committee for the AGM 2023

Pandox AB (publ) (OM:PNDX B) agreed to acquire NH Brussels Louise in central Brussels from NH Hotel Group, S.A. (BME:NHH).

Consensus forecasts updated

Investor sentiment improved over the past week

Price target increased to kr168

Second quarter 2022 earnings: Revenues exceed analyst expectations

Pandox AB (publ), Annual General Meeting, Apr 12, 2023

Pandox AB (Publ) Announces Executive Changes

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2023 Results on Feb 08, 2024

Director recently bought kr401k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Consensus EPS estimates fall by 28%